NSE · Healthcare · Drug Manufacturers - Specialty & Generic
with an average price target of ₹7,090.00.
| Holder | Stake |
|---|---|
| Nippon Life India Trustee Ltd-a/c Nippon India Sma | 4.18% |
| Life Insurance Corporation of India | 1.91% |
| Uti-mnc Fund | 1.69% |
| Aditya Birla Sun Life Trustee Private Limited A/C | 1.22% |
| Document | Date |
|---|---|
| Annual report FY2026 PROCTER & GAMBLE HEALTH LIMITED – ANNUAL REPORT FY 2025-26 SUMMARY HEADLINE NUMBERS • Revenue from operations: ₹1,40,797 lakhs (FY 2025-26) vs ₹93,4 | 2026-08-12 |
| Quarterly results · Q1 FY27 PROCTER & GAMBLE HEALTH LIMITED – Q1 FY2026-27 RESULTS SUMMARY HEADLINE NUMBERS • Sales: ₹356 crores, up 7% year-on-year • Reported Profit After Tax | 2026-08-06 |
| Q4 FY26 earnings call PROCTER & GAMBLE HEALTH LIMITED – INVESTOR SUMMARY Analysts Call, June 18, 2026 --- HEADLINE NUMBERS • Sales FY 2025-26: ₹1,400 crore, up 16% year- | 2026-06-18 |
| Investor presentation · Q4 FY26 PROCTER & GAMBLE HEALTH LIMITED – INVESTOR SUMMARY Presentation Date: June 18, 2026 --- HEADLINE NUMBERS • FY 2025-26 Net Sales: INR 1,408 crores – | 2026-06-18 |
| Quarterly results · Q4 FY26 PROCTER & GAMBLE HEALTH LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Net Profit FY 2025-26: ₹32,691 lakhs (full year, 12 months ended March 31, 20 | 2026-05-26 |
| Quarterly results · Q3 FY26 PROCTER & GAMBLE HEALTH LIMITED – Q3 FY2025-26 RESULTS SUMMARY HEADLINE NUMBERS • Q3 FY2025-26 Revenue from Operations: ₹37,386 lakhs (vs ₹30,977 la | 2026-02-06 |
| Quarterly results · Q2 FY26 PROCTER & GAMBLE HEALTH LIMITED – Q2 FY2025-26 RESULTS SUMMARY HEADLINE NUMBERS • Quarter ended September 30, 2025: Unaudited financial results appr | 2025-11-05 |
| Annual report FY2025 PROCTER & GAMBLE HEALTH LIMITED - FINANCIAL SUMMARY Annual Report 2024-25 (Nine Months Ended March 31, 2025) --- HEADLINE NUMBERS • Revenue from Op | 2025-08-06 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹45 / share ex-date Aug 27, 2026 | 2026-08-27 |
| Dividend | ₹110 / share ex-date Feb 12, 2026 | 2026-02-12 |
| Announcement | Date |
|---|---|
| Interim dividend of 160 per share declared including 50 special dividend Procter & Gamble Health Limited's Board of Directors declared an interim dividend of Rs. 160 per equity share on February 6, 2026. This includes a special one-time dividend of Rs. 50 per sha | 2026-02-06 |
| Interim dividend of Rs. 160 per share declared including special dividend Procter & Gamble Health Limited announced an interim dividend of Rs. 160 per equity share, declared by the Board of Directors on February 6, 2026. This comprises a regular interim dividend p | 2026-02-06 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Procter & Gamble Health Limited — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.